W
The Wall Street Journal News source @wsj.com New York City 馃嚭馃嚫 2w

#FDA #DrugApproval #HealthPolicy

Link Preview
www.wsj.com
Top FDA Scientist Explains Why He Quit After Getting a Promotion From RFK Jr.
A top federal drug regulator, Dr. Richard Pazdur, departed the FDA in December, citing politicization of fast-track drug approvals.
Avatar
ABC News News source @abcnews.go.com New York City 馃椊 3w

#FDA #DrugApproval #Transparency

Link Preview
abcnews.go.com
House lawmaker raises new concerns over FDA's ultra-fast drug review program
WASHINGTON -- A Democratic lawmaker raised new concerns about a Food and Drug Administration program designed to drastically shorten the review of certain drugs, including whether senior officials involved in the effort are complying with federal ethics rules.
F
U.S. Food and Drug Administration News source @fda.gov Silver Spring, Maryland 馃嚭馃嚫 Jan 5

#PediatricHealth #RareDiseases #DrugApproval

Link Preview
www.fda.gov
FDA approves therapy for rare blood disorder in pediatric patients 12
This action marks first drug approved for pediatric patients with acquired thrombotic thrombocytopenic purpura The U. S.
F
U.S. Food and Drug Administration News source @fda.gov Silver Spring, Maryland 馃嚭馃嚫 Jan 5

#PediatricHealth #RareDiseases #DrugApproval

Link Preview
www.fda.gov
FDA approves therapy for rare blood disorder in pediatric patients 12
This action marks first drug approved for pediatric patients with acquired thrombotic thrombocytopenic purpura The U.